Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial (Q37240846)
Jump to navigation
Jump to search
scientific article published on 29 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial |
scientific article published on 29 June 2015 |
Statements
1 reference
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial (English)
1 reference
Wolfgang Wick
1 reference
Timothy Cloughesy
1 reference
Albert Lai
1 reference
Lauren E Abrey
1 reference
Heidi S Phillips
1 reference
Thomas Sandmann
1 reference
Ryo Nishikawa
1 reference
Roger Henriksson
1 reference
Frank Saran
1 reference
Nicola Moore
1 reference
Priti Hegde
1 reference
Josep Garcia
1 reference
Congfen Li
1 reference
Warren Mason
1 reference
Samir Kharbanda
1 reference
Franklin Peale
1 reference
Carlos Bais
1 reference
1 reference
Identifiers
1 reference